Annual Report >
Consolidated Financial Highlights
Evaluations
Board of Directors
Management Team
Business
Other Group Companies
Support Services
|
Consolidated Financial Highlights
(Amount expressed in Trillion
of Turkish Lira (TL) in terms of the purchasing power of TL and Millions
of US Dollars at 31 December 1999.)
Balance Sheets As Of 31 December 1999 and 1998
|
1999 |
1998 |
|
TL |
$ |
TL |
$ |
| Current assets |
209 |
387 |
255 |
471 |
| Long-term assets |
835 |
1,546 |
846 |
1,567 |
| Total assets |
1,044 |
1,933 |
1,101 |
2,038 |
| Current liabilities |
148 |
274 |
177 |
329 |
| Long-term liabilities |
188 |
348 |
211 |
389 |
| Minority interest |
302 |
559 |
303 |
561 |
| Shareholders' equity |
406 |
752 |
410 |
759 |
| Total liabilities and shareholders' equity |
1,044 |
1,933 |
1,101 |
2,038 |
Statements of Income for the years ended 31 December 1999 and 1998
|
1999 |
1998 |
|
TL |
$ |
TL |
$ |
| Net sales |
671 |
1,242 |
595 |
1,102 |
| Cost of sales |
521 |
965 |
403 |
746 |
| Gross profit |
150 |
278 |
192 |
355 |
| Finance expenses(net) |
84 |
156 |
70 |
130 |
| Operating expenses |
146 |
270 |
141 |
261 |
| Other expenses |
7 |
13 |
19 |
35 |
| Taxation |
35 |
65 |
9 |
17 |
| Monetary gain/(loss) |
97 |
180 |
64 |
118 |
| Net income/(loss)after taxation and moneratary gain |
(25) |
(46) |
17 |
31 |
| Minority interest |
12 |
22 |
(9) |
(17) |
| Net income/(loss) |
(13) |
(24) |
8 |
15 |
| Earning before interest and taxes(EBIT) |
94 |
174 |
96 |
178 |
| Deprecation and amortisation |
61 |
113 |
60 |
111 |
| Earnings before interest, taxes and deprecation(EBITDA) |
155 |
287 |
156 |
289 |
| Net financial dept |
171 |
317 |
211 |
391 |
Financial Ratios (%)
|
1999 |
1998 |
| Current assets/Current liabilities |
1.41 |
1.44 |
| Current liabilities/total assets |
0.44 |
0.46 |
| Total liabilities/Total assets |
0.32 |
0.35 |
| Net financial dept/Total assets |
0.16 |
0.19 |
| Total liabilities/(shareholders equity+Minority interest) |
0.47 |
0.54 |
| Gross profit/Net sales |
0.22 |
0.32 |
| Financial expencive/Net sales |
0.13 |
0.12 |
|